Halo Labs (WSLFF) Stock Price, News & Analysis

Company Overview

Halo Labs (OTCMKTS: WSLFF) is a California‐based company specializing in the cultivation, extraction and manufacturing of cannabis products. Through its vertically integrated platform, the company oversees every stage of production, from greenhouse and indoor grow rooms to cryogenic extraction and post‐processing. Its core output includes cannabis oils, live resin concentrates, vape cartridges, prerolls and infused edibles, which are regulated under California’s Medicinal and Adult‐Use Cannabis Regulation and Safety Act (MAUCRSA).

In addition to consumer‐facing products, Halo Labs operates West Coast Labs, a state-certified analytical testing and research division. West Coast Labs offers potency testing, pesticide screening, terpene analysis and custom research services for licensed cultivators and manufacturers. This in‐house testing capability supports both the company’s own brand quality control and a suite of white-label and toll‐processing services for third‐party customers seeking turnkey extraction and packaging solutions.

The company’s origins trace back to a specialized analytical lab established to serve California’s emerging cannabis industry. In 2019, it consolidated its testing, extraction and manufacturing businesses under the Halo Labs name to reflect its expanded consumer product portfolio. Halo Labs is led by CEO Mikael MacGregor, whose team brings decades of combined experience in horticulture, analytical chemistry and consumer packaged goods development.

Headquartered in Southern California, Halo Labs supplies licensed dispensaries and distribution partners throughout the state’s key markets. By combining proprietary cryogenic extraction techniques with rigorous in‐house testing protocols, the company aims to deliver consistent, high‐quality cannabis concentrates that meet the evolving demands of both medical patients and adult-use consumers.

Key Stats

• Today's Range: $0.06 to $0.06
• 50-Day Range: $0.04 to $0.06
• 52-Week Range: $0.05 to $2.44
• Volume: 30,240 shs
• Average Volume: 44,446 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WSLFF Stock Analysis - Frequently Asked Questions

How have WSLFF shares performed this year?

Halo Labs' stock was trading at $0.0481 at the start of the year. Since then, WSLFF shares have increased by 31.9% and is now trading at $0.0635.

How do I buy shares of Halo Labs?

Shares of WSLFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:WSLFF
• CIK: N/A
• Web: www.westleaf.com
• Phone: 403 801 7612
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A